In fact, the authors attributed the difference in the expression of TIM-3 to a transient upregulation of plasma glucose levels during the early stages of T2D, with a restoration of the T cells function in long-term T2D. This evidence concerns the gene HAVCR2 and type 2 diabetes mellitus.